GSK plc (GSK) — Stock analysis
GBpCurrent price
1888,50 £
-29,50 £ (-1.54%) today
Market signals
About GSK plc
GSK (formerly GlaxoSmithKline) is one of the world's largest pharmaceutical and vaccine companies. Main areas are vaccines (Shingrix for shingles, among the world's top-selling), specialty medicines (oncology, infectious diseases, immunology) and general medicines. In 2022 it separated its consumer healthcare division into Haleon plc (separately listed). Headquartered in London. FTSE 100 component.
What does GSK do?▾
GSK develops and markets vaccines (Shingrix for shingles, meningococcal and flu vaccines) and drugs for respiratory diseases, HIV (ViiV Healthcare joint venture), oncology and infectious diseases. It separated consumer health products (Sensodyne, Voltaren, Panadol) into Haleon in 2022.
Which exchange is GSK listed on?▾
GSK is listed on the London Stock Exchange with ticker GSK. It is a FTSE 100 component. It also has ADRs on NYSE with ticker GSK.
Does GSK pay dividends?▾
Yes. It pays a quarterly dividend. Yield is typically 3–4%.
Analyse this stock with AI
Create a free account and get 2 credits to generate a complete analysis.
Create account · 2 free credits